v3.26.3
SUMMARY OF CHANGES IN WARRANTS (Details) - $ / shares
 12 Months Ended
Jul. 31, 2026
Jul. 31, 2025
Share Purchase Warrants [Member]    
Accumulated Other Comprehensive Income (Loss) [Line Items]    
Number of warrants outstanding, beginning balance 1,653,914 70,163
Weighted average exercise price, beginning balance [1] $ 58.27 $ 738.36
Number of warrants outstanding, exercised   (6,437)
Weighted average exercise price, exercised [1]   $ 127.50
Number of warrants outstanding, granted 5,366,726 34,190
Weighted average exercise price, granted [1] $ 6.93 $ 127.50
Number of warrants outstanding, expired (26,324)  
Weighted average exercise price, expired [1] $ 794.02  
Number of warrants outstanding, ending balance 6,994,316 1,653,914
Weighted average exercise price, ending balance [1] $ 16.11 $ 58.27
Share Purchase Warrants One [Member]    
Accumulated Other Comprehensive Income (Loss) [Line Items]    
Number of warrants outstanding, granted   49,333
Weighted average exercise price, granted [1]   $ 140.63
Share Purchase Warrants Two [Member]    
Accumulated Other Comprehensive Income (Loss) [Line Items]    
Number of warrants outstanding, granted   306,665
Weighted average exercise price, granted [1]   $ 52.50
Share Purchase Warrants Three [Member]    
Accumulated Other Comprehensive Income (Loss) [Line Items]    
Number of warrants outstanding, granted   1,200,000
Weighted average exercise price, granted [1]   $ 15.00
Compensation Warrants [Member]    
Accumulated Other Comprehensive Income (Loss) [Line Items]    
Number of warrants outstanding, beginning balance 28,072 644
Weighted average exercise price, beginning balance [2] $ 93.54 $ 587.30
Number of warrants outstanding, granted 161,001 4,108
Weighted average exercise price, granted [2] $ 8.39 $ 129.38
Number of warrants outstanding, expired (311)  
Weighted average exercise price, expired [2] $ 842.52  
Number of warrants outstanding, ending balance 261,227 28,072
Weighted average exercise price, ending balance [2] $ 15.34 $ 93.54
Compensation Warrants One [Member]    
Accumulated Other Comprehensive Income (Loss) [Line Items]    
Number of warrants outstanding, granted 72,465 1,709
Weighted average exercise price, granted [2] $ 4.06 $ 182.81
Compensation Warrants Two [Member]    
Accumulated Other Comprehensive Income (Loss) [Line Items]    
Number of warrants outstanding, granted   2,466
Weighted average exercise price, granted [2]   $ 140.63
Compensation Warrants Three [Member]    
Accumulated Other Comprehensive Income (Loss) [Line Items]    
Number of warrants outstanding, granted   3,812
Weighted average exercise price, granted [2]   $ 50.00
Compensation Warrants Four [Member]    
Accumulated Other Comprehensive Income (Loss) [Line Items]    
Number of warrants outstanding, granted   15,333
Weighted average exercise price, granted [2]   $ 56.50
[1] See note 7(a).
[2] Certain BriaCell Legacy Warrants issued prior to August 1, 2022 contain terms that require the related warrant obligations to be recorded at fair value under U.S. GAAP. As a result, the warrant liability is remeasured at the end of each reporting period. For the year ended July 31, 2026, the Company recorded a gain on the revaluation of the warrant liability of $298,733 in the consolidated statements of operations and comprehensive loss.